Interactions between Xenobiotics and DME (XEOTIC)
|
Fungicide(s), Herbicide(s) or Insecticide(s) |
Herbicide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Atrazine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00969
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Herbicide |
DME Modulation |
Atrazine induces the drug-metabolizing activity of DME GSR |
[1] |
Pesticide/Insecticide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Carbamate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00823
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Pesticide/Insecticide |
DME Modulation |
Carbamate inhibits the drug-metabolizing activity of DME GSR |
[2] |
Health or Environmental Toxicant(s) |
Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 6 Xenobiotics
|
Acrylamide |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01187
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Acute Toxic Substance |
DME Modulation |
Acrylamide induces the drug-metabolizing activity of DME GSR |
[3] |
Allyl isothiocyanate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00852
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Acute Toxic Substance |
DME Modulation |
Allyl isothiocyanate inhibits the drug-metabolizing activity of DME GSR |
[4] |
Cadmium |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01503
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Acute Toxic Substance |
DME Modulation |
Cadmium induces the drug-metabolizing activity of DME GSR |
[5] |
Chlorpyrifos |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01248
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Chlorpyrifos up-regulates the expression of DME GSR |
[6] |
Glutaral |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01316
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Acute Toxic Substance |
DME Modulation |
Glutaral inhibits the drug-metabolizing activity of DME GSR |
[7] |
Paraquat |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01422
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Paraquat inhibits the expression of DME GSR |
[8] |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Benzo(a)pyrene |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Carcinogen |
DME Modulation |
Benzo(a)pyrene inhibits the drug-metabolizing activity of DME GSR |
[9] |
Environmental Pollutant |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
2-tert-butylhydroquinone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01129
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Environmental Pollutant |
DME Modulation |
2-tert-butylhydroquinone induces the drug-metabolizing activity of DME GSR |
[10] |
Hexyl cinnamic aldehyde |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00985
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Environmental Pollutant |
DME Modulation |
Hexyl cinnamic aldehyde up-regulates the expression of DME GSR |
[11] |
Pterostilbene |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01441
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Environmental Pollutant |
DME Modulation |
Pterostilbene inhibits the expression of DME GSR |
[12], [13] |
Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
N-hexane |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01016
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Health and Environmental Toxicant |
DME Modulation |
N-hexane up-regulates the expression of DME GSR |
[14] |
Chloric acid |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01001
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Health Hazard |
DME Modulation |
Chloric acid inhibits the drug-metabolizing activity of DME GSR |
[15] |
Natural Product(s), Extract(s) or Medicine(s) |
Natural Mixture |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Tobacco smoke pollution |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00821
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Natural Mixture |
DME Modulation |
Tobacco smoke pollution inhibits the drug-metabolizing activity of DME GSR |
[16] |
Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 5 Xenobiotics
|
Acylfulvene |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01188
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Natural Product |
DME Modulation |
Acylfulvene inhibits the drug-metabolizing activity of DME GSR |
[17] |
Benzyl isothiocyanate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01217
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Natural Product |
DME Modulation |
Benzyl isothiocyanate inhibits the drug-metabolizing activity of DME GSR |
[4] |
Cinnamic aldehyde |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01253
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
Cinnamic aldehyde up-regulates the expression of DME GSR |
[18] |
Gallocatechol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01542
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Natural Product |
DME Modulation |
Gallocatechol induces the drug-metabolizing activity of DME GSR |
[19] |
Illudin S |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01339
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Natural Product |
DME Modulation |
Illudin S inhibits the drug-metabolizing activity of DME GSR |
[17] |
Plant Extract |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Plant extracts |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01574
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Plant Extract |
DME Modulation |
Plant extracts induces the drug-metabolizing activity of DME GSR |
[20] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 21 Xenobiotics
|
Acetaminophen |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Acetaminophen up-regulates the expression of DME GSR |
[21] |
Arsenic trioxide |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00339
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Arsenic trioxide up-regulates the expression of DME GSR |
[22], [23] |
Azathioprine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00007
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Azathioprine up-regulates the expression of DME GSR |
[24] |
Bortezomib |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00159
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Bortezomib up-regulates the expression of DME GSR |
[25] |
Carmustine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00012
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Carmustine inhibits the drug-metabolizing activity of DME GSR (IC50 = 8.1 microM) |
[26] |
Cidofovir |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00132
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cidofovir up-regulates the expression of DME GSR |
[27] |
Cisplatin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cisplatin inhibits the drug-metabolizing activity of DME GSR |
[28] |
Copper sulfate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Copper sulfate up-regulates the expression of DME GSR |
[29] |
Cyclosporine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cyclosporine up-regulates the expression of DME GSR |
[30] |
Dexamethasone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00088
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Dexamethasone up-regulates the expression of DME GSR |
[31] |
Disulfiram |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00028
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Disulfiram up-regulates the expression of DME GSR |
[11] |
Hydrogen peroxide |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00388
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Hydrogen peroxide induces the drug-metabolizing activity of DME GSR |
[32] |
Ifosfamide |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00046
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Ifosfamide up-regulates the expression of DME GSR |
[27] |
Lindane |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00740
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Lindane up-regulates the expression of DME GSR |
[24] |
Obeticholic acid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00165
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Obeticholic acid up-regulates the expression of DME GSR |
[33] |
Pyrithione zinc |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00399
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Pyrithione zinc up-regulates the expression of DME GSR |
[34] |
Testosterone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00095
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Testosterone induces the drug-metabolizing activity of DME GSR |
[35] |
Tretinoin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00253
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Tretinoin induces the drug-metabolizing activity of DME GSR |
[36] |
Benzoic acid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00447
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Marketed but not Approved by US FDA |
DME Modulation |
Benzoic acid up-regulates the expression of DME GSR |
[11] |
Clodronic acid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00465
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Marketed but not Approved by US FDA |
DME Modulation |
Clodronic acid up-regulates the expression of DME GSR |
[27] |
Thiostrepton |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01485
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Marketed but not Approved by US FDA |
DME Modulation |
Thiostrepton induces the drug-metabolizing activity of DME GSR |
[37] |
Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Epigallocatechin gallate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00613
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Epigallocatechin gallate induces the drug-metabolizing activity of DME GSR |
[19] |
Resveratrol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00568
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Resveratrol up-regulates the expression of DME GSR |
[38] |
Sulforafan |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01478
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Sulforafan up-regulates the expression of DME GSR |
[39] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 7 Xenobiotics
|
Bisphenol A |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Bisphenol A up-regulates the expression of DME GSR |
[40] |
Ethanol |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00539
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Ethanol inhibits the drug-metabolizing activity of DME GSR |
[41] |
Genistein |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00557
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Genistein inhibits the expression of DME GSR |
[42] |
Glutathione |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00542
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Glutathione inhibits the drug-metabolizing activity of DME GSR |
[43] |
MGI-114 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00625
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
MGI-114 inhibits the drug-metabolizing activity of DME GSR |
[17] |
Motexafin gadolinium |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00541
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Motexafin gadolinium induces the drug-metabolizing activity of DME GSR |
[44] |
Selenic acid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00575
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Selenic acid up-regulates the expression of DME GSR |
[45] |
Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 6 Xenobiotics
|
Dihydrotestosterone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00536
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Dihydrotestosterone up-regulates the expression of DME GSR |
[46] |
Dinitrochlorobenzene |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00571
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Dinitrochlorobenzene up-regulates the expression of DME GSR |
[11] |
Hexylresorcinol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01329
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Hexylresorcinol induces the drug-metabolizing activity of DME GSR |
[47] |
Homocysteine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01331
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Homocysteine inhibits the drug-metabolizing activity of DME GSR |
[48] |
Sodium arsenite |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00632
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Sodium arsenite up-regulates the expression of DME GSR |
[49] |
Thioctic acid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01483
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Thioctic acid up-regulates the expression of DME GSR |
[50] |
Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 5 Xenobiotics
|
Kolaviron |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01358
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug in Preclinical Study |
DME Modulation |
Kolaviron induces the drug-metabolizing activity of DME GSR |
[1] |
Anethole trithione |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00729
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Patented Pharmaceutical Agent |
DME Modulation |
Anethole trithione induces the drug-metabolizing activity of DME GSR |
[51] |
Eugenol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00885
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Patented Pharmaceutical Agent |
DME Modulation |
Eugenol up-regulates the expression of DME GSR |
[11] |
ICG-001 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01336
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Patented Pharmaceutical Agent |
DME Modulation |
ICG-001 inhibits the expression of DME GSR |
[52] |
K-7174 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01348
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Patented Pharmaceutical Agent |
DME Modulation |
K-7174 up-regulates the expression of DME GSR |
[53] |
Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 4 Xenobiotics
|
Chlorite |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00807
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Investigative Agent |
DME Modulation |
Chlorite inhibits the drug-metabolizing activity of DME GSR |
[54] |
Indirubin-3'-monoxime |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01342
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Investigative Agent |
DME Modulation |
Indirubin-3'-monoxime up-regulates the expression of DME GSR |
[55] |
Isopropanol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01128
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Investigative Agent |
DME Modulation |
Isopropanol up-regulates the expression of DME GSR |
[11] |
Phenylmercuric acetate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00818
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Investigative Agent |
DME Modulation |
Phenylmercuric acetate induces the drug-metabolizing activity of DME GSR |
[56] |
Other Chemical Compound(s) or Element(s) |
Chemical Compound |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Cupric oxide |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00840
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Chemical Compound |
DME Modulation |
Cupric oxide inhibits the drug-metabolizing activity of DME GSR |
[57] |
|
|
|
|
|
|